Testagen

Testagen peptide is a synthetic ultrashort tetrapeptide also referred to as KEDG, composed of lysine, glutamic acid, aspartic acid, and glycine. In the published peptide literature, it is described as a bioregulatory compound studied in experimental endocrine and male reproductive system research, with broader interest in peptide-mediated control of gene expression, intracellular signaling, and cellular adaptation. Due to its compact structure, this compound is also relevant in laboratory models focused on regulatory peptide biology and nucleus-associated activity.

Research interest in Testagen has focused on its role as an ultrashort regulatory peptide within endocrine and reproductive biology. A systematic review of peptide regulation of gene expression specifically lists KEDG in connection with regulation of male reproductive system function, while broader peptide-gene regulation literature describes short peptides as modulators of transcriptional activity, differentiation, proliferation, and apoptosis in experimental systems. These findings support the positioning of Testagen peptide as a research compound in studies of endocrine balance, reproductive signaling, and peptide-mediated cellular regulation (Khavinson et al., 2021 — International Journal of Molecular Sciences).

Beyond endocrine-focused research, Testagen has attracted attention for its interactions with nucleic acids and for the broader transport behavior of ultrashort peptides. Experimental work with fluorescence-labeled short peptides reported that testagen preferentially bound deoxyribooligonucleotides containing CAG sequences, while later transport-focused reviews described ultrashort peptides as candidates for carrier-mediated cellular uptake. Together, these observations support continued research into Testagen peptide as a model compound for peptide-DNA interactions, intracellular signaling, regulatory peptide transport, and age-related cellular research. This broader mechanistic profile makes the peptide relevant in experimental work examining how short bioregulators may influence nuclear activity and gene-expression-associated pathways (Fedoreyeva et al., 2011 — Neurochemical Journal; Khavinson et al., 2022 — International Journal of Molecular Sciences).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.